Joanne Matos, 37, was born with an enlarged heart and has congestive heart failure. Despite a stroke and two silent heart ...

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

The most common cardiovascular killer in maternal medicine is also among the most misdiagnosed. Peripartum cardiomyopathy ...

The artificial intelligence model predicts patients’ heart disorders and risk of future heart failure using just an ...

Bhubaneswar: The Kalinga Institute of Medical Sciences (KIMS) here has become the first in Odisha to introduce the ...

Landing in the hospital with COVID or the flu can put your heart health at dire risk, a new study suggests.Adults hospi ...

February is American Heart Month and WHSV is partnering with Augusta Health to highlight the importance of cardiovascular health.

Cumberland Pharmaceuticals' Phase 2 trial shows ifetroban improves heart function in Duchenne muscular dystrophy patients.

Fresh from FDA approval for its paediatric stem-cell product, Mesoblast is pursuing consent for indications of heart disease ...

Background Early heart failure (HF) diagnosis is crucial to ensure that optimal guideline-directed medical therapy (GDMT) is ...

A specially designed drug prevented laboratory mice from developing heart failure after heart attacks, according to new ...

Dr. Guruprasad “Guru” Srinivas told the Post that not all heart attack symptoms involve chest pain. He revealed which lesser-known symptoms to look out for.